[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Views 1,338
    Citations 0
    Research Letter
    July 30, 2020

    Opioid Use and Pain Control After Total Hip and Knee Arthroplasty in the US, 2014 to 2017

    Author Affiliations
    • 1School of Medicine, University of Texas Medical Branch, Galveston
    • 2Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston
    • 3Office of Biostatistics, University of Texas Medical Branch, Galveston
    • 4Division of Geriatrics and Palliative Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston
    JAMA Netw Open. 2020;3(7):e2011972. doi:10.1001/jamanetworkopen.2020.11972

    Potential overprescribing of opioids after surgery may contribute to opioid-related adverse events.1,2 The proportion of opioid-naive patients with a new opioid prescription within 7 days after total knee arthroplasty (TKA) increased from 79.1% in 2004 to 82.0% in 2012.3 The US Drug Enforcement Administration in 2014,4 the US Centers for Disease Control and Prevention in 2016,5 and health systems, state governments, and health payers all implemented myriad policies to restrict opioid overprescribing. The impact of these policies on postoperative opioid prescribing is unknown. We examined rates of opioid prescribing and level of pain control in patients who underwent total hip arthroplasty (THA) and TKA from 2014 to 2017.